Clinical trials
Withdrawn Phase 1/2 Myelodysplastic Syndromes trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 4 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 2 |
| Alliance for Clinical Trials in Oncology | 1 |
| Bio-Path Holdings, Inc. | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Genzyme, a Sanofi Company | 1 |
| Groupe Francophone des Myelodysplasies | 1 |
| Hadassah Medical Organization | 1 |
| Indiana University | 1 |
| Naoyuki G. Saito, M.D., Ph.D. | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 19 |
| Leukemia, Myeloid, Acute | 12 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Leukemia | 5 |
| Leukemia, Myelomonocytic, Chronic | 5 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 |
| Myeloproliferative Disorders | 4 |
| Congenital Abnormalities | 3 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 |
| Leukemia, Myeloid, Accelerated Phase | 3 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.